Name: 北美亨特氏综合征治疗市场 – 行业趋势和 2028 年预测
Brand: Data Bridge Market Research
SKU: 64195
Price: 3500.00 USD
Availability: InStock
Rating: 4.5 (51 reviews)

市场分析和见解：北美亨特氏综合征治疗市场

北美亨特氏综合症治疗市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场的复合年增长率为 9.3%，预计到 2028 年将达到 6.5266 亿美元。公共和私营公司对研发投资的增加以及技术进步是推动预测期内市场需求的主要驱动力。

亨特综合征是一种罕见的遗传性疾病，由酶艾杜糖醛酸-2-硫酸酯酶缺失或功能障碍引起。由于这种原因，身体无法正常消化或分解体内的糖分子。当这些分子随着时间的推移在器官和组织中积聚时，它们会造成损害，影响身体和智力的发育和能力。这种疾病几乎总是发生在男孩身上。这种疾病是一组称为粘多糖贮积症 (MPS) 的遗传性代谢疾病中的一种。

亨特综合征是一种罕见的遗传性疾病，患者身体无法正常消化（分解）体内的糖分子。当这些分子随着时间的推移在器官和组织中积累时，它们会造成损害，影响身体和智力的发育和能力。

公众对这种综合症及其治疗方案的认识、医疗基础设施的改善以及政府为促进全球医疗行业发展而增加的投资，可能会加速北美亨特氏综合症治疗市场在预测期内的增长。另一方面，有利的政府举措和技术进步将进一步为上述预测期内亨特氏综合症治疗市场的增长带来巨大机会。然而，与治疗相关的不良影响、病因不明和患病率低是预计会在预测期内抑制市场增长的因素。

The hunter syndrome treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

North America Hunter Syndrome Treatment Market Scope and Market Size

Hunter syndrome treatment market is segmented on the basis of severity, types, complications, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

On the basis of severity, the North America hunter syndrome treatment market is segmented into mild to moderate and moderate to severe. In 2021, the moderate to severe segment is dominating the North America hunter syndrome treatment market due to growing R&D activities.
On the basis of type, the North America hunter syndrome treatment market is segmented into enzyme replacement therapy (ERT), stem cell transplant, surgical treatment and others. In 2021, enzyme replacement therapy (ERT) is dominating the North America hunter syndrome treatment market due to somatic improvement, such as reduction in the frequency of respiratory infections, among others.
On the basis of complications, the North America hunter syndrome treatment market is segmented into respiratory disorders, neurological disorders, gastrointestinal disorders, cardiovascular, ophthalmic, audiologic, dental, musculoskeletal, others. In 2021, the respiratory disorders segment is dominating the North America hunter syndrome treatment market due to increasing R & D capabilities predicted to improve patient outcomes.
On the basis of end user, the North America hunter syndrome treatment market is segmented into hospitals, clinics, home healthcare and others. In 2021, the hospitals segment is dominating the North America hunter syndrome treatment market due to increased patient satisfaction, coupled with cost reduction.
On the basis of distribution channel, the North America hunter syndrome treatment market is segmented into hospital pharmacy, retail pharmacy, online pharmacy and others. In 2021, hospital pharmacy segment is dominating the North America hunter syndrome treatment market due to greater input in prescribing decisions about drugs and administration.

Hunter Syndrome Treatment Market Country Level Analysis

The hunter syndrome treatment market is analyzed and market size information is provided on the basis of severity, types, complications, end user and distribution channel.

The countries covered in the hunter syndrome treatment market report are U.S., Canada and Mexico.

Enzyme replacement therapy (ERT) segment in North America region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of rise in clinical trials and increasing innovative R&D investments.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

The Increase in the Cases of Inherited Genetic Disorders among Population across the Globe and Favorable Government Initiatives are Boosting the Market Growth of Hunter Syndrome Treatment Products

Hunter syndrome treatment market also provides you with detailed market analysis for every country growth in hunter syndrome treatment products industry with drugs sales, impact of advancement, technology and changes in regulatory scenarios with their support for the hunter syndrome treatment market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Hunter Syndrome Treatment Market Share Analysis

Hunter syndrome treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to hunter syndrome treatment market.

The major companies operating in the North America hunter syndrome treatment are Takeda Pharmaceutical Company Limited, Medtronic, Abbott, On-X Life Technologies (a subsidiary of CryoLife Inc.), BD, Johnson & Johnson Services, Inc., Medical Device Business Services Inc., Stryker, Homology Medicines, Inc., UCB S.A., Novartis AG, Inventiva, Pfizer Inc., JCR Pharmaceuticals Co., Ltd., Sangamo Therapeutics, AVROBIO Inc., REGENXBIO Inc., CANbridge Life Sciences Ltd., Denali Therapeutics, and Jasper Therapeutics, among others.

全球范围内的许多产品发布和协议也由公司发起，这也加速了猎人综合征治疗市场的发展。

例如，

2021 年 3 月，儿童国家医院和武田制药有限公司宣布成立罕见病临床活动方案 (Rare-CAP) 项目，该项目将建立一个用于开发、传播和整理方案的网络系统，以帮助标准化罕见病患者的诊断和护理流程。此次合作凸显了各公司致力于推动罕见病患者的持续创新和个性化护理的承诺。
2021 年 1 月，Green Cross Corp. 宣布 Hunterase ICV（脑室内）注射液 15 毫克（通用名：idursulfase-beta（重组））获得营销和生产批准，用于治疗 MPS II（亨特综合征）。这有助于该公司开发和商业化该治疗方法，以满足罕见病患者尚未满足的需求。
2021 年 1 月，辉瑞公司宣布，在 2020 年下半年，作为辉瑞突破性增长计划 (PBGI) 的一部分，它向四家临床阶段生物技术公司投资了总计 1.2 亿美元。辉瑞正在向各种生物技术公司投资约 5 亿美元。这项投资将帮助辉瑞确保有前景的临床开发计划的连续性，以实现未来的战略利益。它帮助该公司通过进入和创新新产品来扩展业务。

市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业和其他策略正在增强公司在猎人综合征治疗市场中的市场，这也为组织改善其对猎人综合征治疗药物的供应提供了好处。

SKU-64195

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Request for Demo

表格列表

LIST OF TABLES

TABLE 1 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 2 NORTH AMERICA MODERATE TO SEVERE IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 NORTH AMERICA MILD TO MODERATE IN NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 4 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 5 NORTH AMERICA ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 NORTH AMERICA ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 7 NORTH AMERICA STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 NORTH AMERICA STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 9 NORTH AMERICA SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 NORTH AMERICA SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 11 NORTH AMERICA OTHERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)

TABLE 13 NORTH AMERICA RESPIRATORY DISORDERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 NORTH AMERICA NEUROLOGICAL DISORDERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 NORTH AMERICA CARDIOVASCULAR IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 NORTH AMERICA MUSCULOSKELETAL IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 NORTH AMERICA GASTROINTESTINAL DISORDERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 NORTH AMERICA OPHTHALMIC IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 NORTH AMERICA AUDIOLOGIC IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 NORTH AMERICA DENTAL IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 NORTH AMERICA OTHERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET: BY END USER, 2020

TABLE 23 NORTH AMERICA HOSPITALS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 NORTH AMERICA CLINICS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 NORTH AMERICA HOME HEALTHCARE IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 NORTH AMERICA OTHERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020

TABLE 28 NORTH AMERICA HOSPITAL PHARMACY IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 NORTH AMERICA RETAIL PHARMACY IN HUNTER SYNDROME MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 NORTH AMERICA ONLINE PHARMACY IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 NORTH AMERICA OTHERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 33 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 34 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 35 NORTH AMERICA ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 36 NORTH AMERICA STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 37 NORTH AMERICA SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 38 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)

TABLE 39 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 40 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 41 U.S. HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 42 U.S. HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 43 U.S. ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 44 U.S. STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 45 U.S. SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 46 U.S. HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)

TABLE 47 U.S. HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 48 U.S. HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 49 CANADA HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 50 CANADA HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 51 CANADA ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 52 CANADA STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 53 CANADA SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 54 CANADA HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)

TABLE 55 CANADA HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 56 CANADA HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 57 MEXICO HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 58 MEXICO HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 59 MEXICO ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 60 MEXICO STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 61 MEXICO SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 62 MEXICO HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)

TABLE 63 MEXICO HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 64 MEXICO HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

图片列表

LIST OF FIGURES

FIGURE 1 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET : SEGMENTATION

FIGURE 2 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET : DATA TRIANGULATION

FIGURE 3 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET : DROC ANALYSIS

FIGURE 4 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET : NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET : COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET : INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET : DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET : MARKET END USER COVERAGE GRID

FIGURE 9 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET : VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET : SEGMENTATION

FIGURE 11 INCREASING PREVALANCE OF HUNTER SYNDROME IS EXPECTED TO DRIVE THE NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 MODERATE TO SEVERE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET IN 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET

FIGURE 14 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET: BY SEVERITY, 2020

FIGURE 17 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET: BY END USER, 2020

FIGURE 18 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 19 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET: SNAPSHOT (2020)

FIGURE 20 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET: BY COUNTRY (2020)

FIGURE 21 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 22 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 23 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET: BY SEVERITY (2021-2028)

FIGURE 24 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET: COMPANY SHARE 2020 (%)

查看详细信息

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.